Identification of rare de novo epigenetic variations in congenital disorders

• Published in: bioRxiv
• Main Authors: Barbosa, Mafalda, Joshi, Ricky S, Garg, Paras, Martin-Trujillo, Alejandro, Patel, Nihir, Jadhav, Bharati, Watson, Corey T, Gibson, William, Kelsey Chetnik, Tessereau, Chloe, Hui, Mei, De Rubeis, Silvia, Reichert, Jennifer, Lopes, Fatima, Vissers, Lisenka, Kleefstra, Tjitske, Grice, Dorothy E, Edelmann, Lisa, Soares, Gabriela, Maciel, Patricia, Brunner, Han G, Buxbaum, Joseph D, Gelb, Bruce D, Sharp, Andrew
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 19.01.2018
• Subjects: Congenital defects; Congenital diseases; Deoxyribonucleic acid; DNA; DNA methylation; DNA microarrays; Epigenetics; Gene expression; Genetic diversity; Genomes; Mutation; Neurodevelopmental disorders; Non-coding RNA; Population studies; Regulatory sequences
• DOI: 10.1101/250787

Certain human traits such as neurodevelopmental disorders (NDs) and congenital anomalies (CAs) are believed to be primarily genetic in origin. With recent dramatic advances in genomic technologies, genome-wide surveys of cohorts of patients with ND/CAs for point mutations and structural variations have greatly advanced our understanding of their genetic etiologies. However, even after whole genome sequencing (WGS), a substantial fraction of such disorders remain unexplained. In contrast, the possibility that constitutive epigenetic variations (epivariations) might underlie such traits has not been well explored. We hypothesized that some cases of ND/CA are caused by aberrations of DNA methylation that lead to a dysregulation of normal genome function. By comparing DNA methylation profiles from 489 individuals with ND/CAs against 1,534 population controls, we identified epivariations as a frequent occurrence in the human genome. De novo epivariations were significantly enriched in cases when compared to controls. RNAseq data from population studies showed that epivariations often have an impact on gene expression comparable to loss-of-function mutations. Additionally, we detected and replicated an enrichment of rare sequence mutations overlapping CTCF binding sites close to epivariations. Thus, some epivariations occur secondary to cis-linked mutations in regulatory regions, providing a rationale for interpreting non-coding genetic variation. We propose that epivariations likely represent the causative genomic defect in 5-10% of patients with unexplained ND/CAs. This constitutes a yield comparable to CNV microarrays, and as such has significant diagnostic relevance.